|
Genetic variants within the glucocorticoids related genes to predict outcome in patients with metastatic colorectal cancer (mCRC). |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Bayer; Sanofi |
Speakers' Bureau - Amgen; Bayer; Roche; Sanofi |
Research Funding - Amgen (Inst); Bayer (Inst); Merck Serono (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Amgen; Bayer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Roche/Genentech |
Stock and Other Ownership Interests - Roche/Genentech |
Patents, Royalties, Other Intellectual Property - Patent |
|
|
Honoraria - Amgen; Bayer; Roche |
Consulting or Advisory Role - Bayer; Lilly; Roche |
|
|
|
Honoraria - Celgene; Lilly; Merck; Roche; SERVIER |
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Lilly; Merck; Roche; Sanofi; SERVIER |
Research Funding - Amgen (Inst); Bayer (Inst); Merck (Inst); MSD (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst) |
|
|
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche |
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche |
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche |